✦Canada Post Xpress1–2 day delivery across CanadaFree on orders over $200
Your cart is empty
Multi-Peptide Research Blend
KLOW is a research blend formulated for investigation into combined metabolic and cellular signaling pathways in laboratory models. Studies typically focus on how its components may interact to influence energy regulation, tissue-related processes, and overall system-level responses within controlled experimental settings.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
KLOW is a multi-peptide research blend integrating GHK-Cu, BPC-157, TB-500, and KPV into a unified formulation developed for controlled laboratory investigation.
In scientific literature, these peptides are studied in experimental models examining cellular signaling pathways, inflammatory modulation frameworks, angiogenic activity, and extracellular matrix regulatory systems. The blend provides a research platform for exploring coordinated peptide interaction within tissue response and regenerative pathway models under in vitro and preclinical conditions.
Third-party tested for purity, ID, quantity.
The KLOW Blend integrates GHK-Cu, BPC-157, TB-500, and KPV into a unified research formulation designed for controlled laboratory study. Each component has been independently examined in preclinical settings involving structural pathway models, inflammatory signaling systems, and cellular response mechanisms.
Within experimental environments, the combined formulation is evaluated for its interaction across tissue remodeling pathways, angiogenic signaling models, extracellular matrix activity, and immune-related regulatory frameworks. The blend provides a structured platform for investigating multi-peptide pathway dynamics and coordinated cellular signaling processes under in vitro and preclinical conditions.
The individual peptides included in KLOW have been studied across several decades of laboratory research. GHK-Cu was first identified in the 1970s in studies examining copper-binding peptides. BPC-157 and TB-500 later emerged in structural peptide research frameworks, while KPV has been investigated within inflammatory signaling models.
KLOW represents a research-based integration of these peptides into a single experimental blend for controlled pathway evaluation.
Laboratory investigations involving the individual components of KLOW have explored structural pathway signaling, inflammatory response models, angiogenic activity frameworks, and extracellular matrix interactions. Research environments examine how multi-peptide systems influence coordinated cellular signaling under controlled in vitro and preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each vial contains 90mg of the KLOW peptide blend. Independent third-party testing verifies purity, identity, and batch composition prior to release.
The vial contains only the lyophilized peptide blend. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research protocol, storage conditions, and laboratory application.
GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration.
PubMedA new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J Physiol Paris 87(5):313–327.
PubMedThymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther 12(1):37–51.
PubMedThe promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985) 110(3):774–780.
PubMedPentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules 19(11):19066–19077.
PubMedPepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 134(1):166–178.
PubMedPentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion. World J Hepatol 12(5):184–206.
PubMedRelated
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$180.00
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$10.00
Immune-modulating peptide studied for T-cell signaling and immune system regulatory pathway research
From$70.00
GHRH analog studied for growth hormone regulation and metabolic pathway signaling research
From$95.00
